AFT Pharmaceuticals (NZX:AFT)
ASX announcement history & article coverage
Transparent by design.
Announcments by AFT Pharmaceuticals (NZX:AFT) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Results of AFT Pharmaceuticals Limited’s 2026 Annual Shareholders’ Meeting
AFT 2026 Annual Meeting Presentation
AFT Chair's Address at the ASM 31 July 2026
AFT Chair David Flacks to retire before the next ASM
AFT Market Release Investor Day Presentation 28 July 2026
AFT R&D portfolio offers multi-billion-dollar market potential
Pitt St Research initiates coverage on AFT Pharmaceuticals
ScomaraTM Tentative Approval by US FDA
FDA Grants Tentative Approval for AFT's Scomara with US Launch Delayed Until 2029
AFT reports ongoing sales growth and R&D progress
AFT Notice of Meeting 2026 Proxy Form
AFT Notice of Meeting of Shareholders 2026
FDA allows AFT’s injectable iron project clinical study
AFT Pharmaceuticals FY26 revenue up 22%, targets $300M in FY27 with global expansion and R&D progress
capital change notice